WASHINGTON, D.C. Scientific breakthroughs in molecular targeting, translational cancer research and cancer prevention will take center stage when more than 17,000 scientists from around the world gather at the Walter E. Washington Convention Center, April 17-21, for the AACR 101st Annual Meeting 2010.
"We are now entering our second century of Annual Meetings and I believe we will have the ability to control this disease in the near term," said Tyler Jacks, Ph.D., president of the American Association for Cancer Research and director of the David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology.
"This does not mean that we will cure all diseases, but cancer patients will experience significantly longer survival, including those with the most devastating diagnosis, as we implement the new approaches we're discovering today," he said.
The theme of the AACR 101st Annual Meeting 2010 is "Conquering Cancer Through Discovery Research," and scientists from many disciplines will present approximately 6,300 abstracts in all aspects of cancer. This year's Annual Meeting will feature an expanded number of plenary sessions where new, exciting information will be presented on familiar topics like cancer genetics, but also new arenas like small RNAs, nanotechnology and systems biology, according to Jacks.
To help guide coverage of the conference, the AACR Communications Department has planned the following five press conferences:
In addition, the American Association for
|Contact: Jeremy Moore|
American Association for Cancer Research